April 25, 2019 Life Science Tools M&A, Partnerships

GrandOmics collaborates with Oxford Nanopore to deliver dbSV-100k, a project to sequence 100,000 affordable nanopore long-read human genomes

Thu 25th April 2019 Strategic collaboration between two organisations represents largest nanopore sequencing project to date, capitalising on recent developments bringing ultra-high yields with PromethION GrandOmics, a leading sequencing company in China, has announced a populational-scale project, dbSV100k, to understand the impact of structural variation on human disease. The project aims to sequence 20,000 human... Read more

January 4, 2017 Life Science Tools M&A, Partnerships Microscopy

GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine Initiative

MENLO PARK, Calif. and BEIJING, Jan. 04, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), today announced that GrandOmics Biosciences Co., Ltd of Beijing, through its subsidiary NextOmics in Wuhan, has agreed to purchase five additional Sequel™ instruments to support China’s precision medicine initiative, with a specific focus on ultimately providing the genetic... Read more